These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 30707883)
1. [Metabolic regulation of immune responses: new perspective for sepsis research]. Jiang Z; Bian J; Deng X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):122-125. PubMed ID: 30707883 [TBL] [Abstract][Full Text] [Related]
2. Specific and Complex Reprogramming of Cellular Metabolism in Myeloid Cells during Innate Immune Responses. Stienstra R; Netea-Maier RT; Riksen NP; Joosten LAB; Netea MG Cell Metab; 2017 Jul; 26(1):142-156. PubMed ID: 28683282 [TBL] [Abstract][Full Text] [Related]
3. The immune system's role in sepsis progression, resolution, and long-term outcome. Delano MJ; Ward PA Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333 [TBL] [Abstract][Full Text] [Related]
4. [New treatment for sepsis: stem cell therapy]. Zhao S; Yang M Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 38(7):754-60. PubMed ID: 23908092 [TBL] [Abstract][Full Text] [Related]
5. Lactate and Immunosuppression in Sepsis. Nolt B; Tu F; Wang X; Ha T; Winter R; Williams DL; Li C Shock; 2018 Feb; 49(2):120-125. PubMed ID: 28767543 [TBL] [Abstract][Full Text] [Related]
6. Role of Toll-like receptor responses for sepsis pathogenesis. Weighardt H; Holzmann B Immunobiology; 2007; 212(9-10):715-22. PubMed ID: 18086373 [TBL] [Abstract][Full Text] [Related]
7. Role of cellular events in the pathophysiology of sepsis. Bhan C; Dipankar P; Chakraborty P; Sarangi PP Inflamm Res; 2016 Nov; 65(11):853-868. PubMed ID: 27392441 [TBL] [Abstract][Full Text] [Related]
8. A New Strategy for Targeting UCP2 to Modulate Glycolytic Reprogramming as a Treatment for Sepsis A New Strategy for Targeting UCP2. Li N; Deng J; Zhang J; Yu F; Ye F; Hao L; Li S; Hu X Inflammation; 2024 Mar; ():. PubMed ID: 38429403 [TBL] [Abstract][Full Text] [Related]
9. Cellular metabolism of myeloid cells in sepsis. Arts RJ; Gresnigt MS; Joosten LA; Netea MG J Leukoc Biol; 2017 Jan; 101(1):151-164. PubMed ID: 27272310 [TBL] [Abstract][Full Text] [Related]
10. The role of proteomics in understanding biological mechanisms of sepsis. Cao Z; Robinson RA Proteomics Clin Appl; 2014 Feb; 8(1-2):35-52. PubMed ID: 24339042 [TBL] [Abstract][Full Text] [Related]
11. Arginine and citrulline and the immune response in sepsis. Wijnands KA; Castermans TM; Hommen MP; Meesters DM; Poeze M Nutrients; 2015 Feb; 7(3):1426-63. PubMed ID: 25699985 [TBL] [Abstract][Full Text] [Related]
12. [Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy]. Martin L; Derwall M; Thiemermann C; Schürholz T Anaesthesist; 2017 Jul; 66(7):479-490. PubMed ID: 28677016 [TBL] [Abstract][Full Text] [Related]
13. DAMPs activating innate immune responses in sepsis. Kang JW; Kim SJ; Cho HI; Lee SM Ageing Res Rev; 2015 Nov; 24(Pt A):54-65. PubMed ID: 25816752 [TBL] [Abstract][Full Text] [Related]
14. Metabolic Reprogramming and Its Regulatory Mechanism in Sepsis-Mediated Inflammation. Liu W; Liu T; Zheng Y; Xia Z J Inflamm Res; 2023; 16():1195-1207. PubMed ID: 36968575 [TBL] [Abstract][Full Text] [Related]
15. Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation. Bettencourt IA; Powell JD J Immunol; 2017 Feb; 198(3):999-1005. PubMed ID: 28115589 [TBL] [Abstract][Full Text] [Related]
16. Sepsis-related alterations in non-immune cell-signaling. Ahmad S Compr Ther; 1995 Dec; 21(12):737-40. PubMed ID: 8789139 [TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor and innate immune responses to bacterial infections. Froidevaux C; Roger T; Martin C; Glauser MP; Calandra T Crit Care Med; 2001 Jul; 29(7 Suppl):S13-5. PubMed ID: 11445727 [TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Oberbeck R; Dahlweid M; Koch R; van Griensven M; Emmendörfer A; Tscherne H; Pape HC Crit Care Med; 2001 Feb; 29(2):380-4. PubMed ID: 11246320 [TBL] [Abstract][Full Text] [Related]
20. Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? Van Wyngene L; Vandewalle J; Libert C EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29976786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]